FSV:CC - Mirum's LIVMARLI receives positive reimbursement recommendation by Canada's CADTH
2024-04-02 08:59:39 ET
More on Mirum Pharmaceuticals
- Mirum Pharmaceuticals: Advancing On Several Key Fronts
- Mirum Pharmaceuticals, Inc. (MIRM) Q4 2023 Earnings Call Transcript
- Mirum Pharmaceuticals, Inc. 2023 Q4 - Results - Earnings Call Presentation
- Mirum gains as FDA accepts label expansion of liver disease drug
- Seeking Alpha’s Quant Rating on Mirum Pharmaceuticals